Failure of 125I-tracer selective monoclonal antibody levels on a whole blood matrix to predict rejection or nephrotoxic episodes in renal transplant patients under anti-lymphocyte globulin and prednisone therapy.
Stiller
C
C
Multi-Organ Transplant Services, University of Western Ontario, London.
Keown
P
P
D000911:Antibodies, Monoclonal; D000961:Antilymphocyte Serum / Q000008:administration & dosage*; D001379:Azathioprine / Q000008:administration & dosage*; D002102:Cadaver; D002851:Chromatography, High Pressure Liquid / Q000379:methods*; D003524:Cyclosporins / Q000008:administration & dosage / Q000009:adverse effects* / Q000493:pharmacokinetics; D004305:Dose-Response Relationship, Drug; D004359:Drug Therapy, Combination; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000187:drug effects*; D006801:Humans; D007668:Kidney / Q000187:drug effects*; D007677:Kidney Function Tests; D016030:Kidney Transplantation / Q000276:immunology*; D011241:Prednisone / Q000008:administration & dosage; D011863:Radioimmunoassay / Q000379:methods*
D000911:Antibodies, Monoclonal; D000961:Antilymphocyte Serum; D003524:Cyclosporins; D001379:Azathioprine; D011241:Prednisone